Trade Technologies has entered into an agreement for a strategic investment from TA Associates, a global private equity firm. The transaction, which ...

Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Investment amounts are estimated between $150-200 million.

The roughly $3.29 billion deal gives Hg control of the company alongside EQT.

Hg increases its stake in enterprise software provider IFS and becomes co-control shareholder alongside EQT, while existing minority shareholder TA Associates remains invested• New investors in this ...

You are viewing content tagged with 'Partner and CoHead of Technology, EQT Private Equity advisory team' - iTWire - Technology News and Jobs Australia ...

Danish asset manager Novo Holdings, which is owned by Novo Nordisk Foundation (NNF), the majority voting shareholder of ...

Trade helps customers grow their electronic trading and payments business through secure, cost-efficient and technologically advanced end-to-end SaaS services.

today announced an investment from TA Associates ("TA"), a leading global private equity firm. This partnership aims to accelerate QIMA’s ambitious growth plans and further disrupt the Testing ...

will join Qima’s board of directors TA Associates has made an investment in Qima, a Hong Kong-based provider of quality control and compliance solutions. No financial terms were disclosed.

QIMA Welcomes TA Associates as a New Strategic Partner to Propel Ambitious Growth Plans in the Testing, Inspection, and Certification Industry QIMA, a leading provider of quality control and ...

The deal, the terms of which have not been disclosed, will give Novo Holdings and TA Associates, shared control of the UK-based manufacturer of products for infection management in bone and soft ...